UEG Week: Long-term aspirin use reduces the incidence of digestive cancers by up to 47%

(Barcelona, October 31, 2017) The long-term use of aspirin has been shown to significantly reduce the incidence of digestive cancers, new research presented today at the 25th UEG Week has found. 

In a study involving over 600,000 people, researchers compared patients who were prescribed aspirin over a long period (for at least six months, average duration of aspirin prescribed was 7.7 years) with non-aspirin users and assessed the incidences of a number of cancers. Those prescribed with aspirin showed a 47% reduction in liver and oesophageal cancer incidence, a 38% reduction in gastric cancer incidence, a 34% reduction in pancreatic cancer incidence and a 24% reduction in colorectal cancer incidence. Digestive cancers account for almost a quarter of cancer cases in Europe. Colorectal, gastric and pancreatic cancer are within the top five cancer killers throughout the continent, with digestive cancers representing 30.1% of cancer deaths.  The effect of long-term use of aspirin on cancer incidence was also examined for cancers outside of the digestive system. Here, a significant reduction was shown for some (leukaemia, lung and prostate) but not all (breast, bladder, kidney and multiple myeloma) cancers.  Aspirin is used across the globe to treat a number of health conditions, ranging from short-term pain relief to long-term prescriptions. Whilst the use of aspirin is subject to debate within the medical community, a recent study found that patients who stopped taking aspirin were 37% more likely to have an adverse cardiovascular event, such as a heart attack or stroke, than those who continued with their prescription. Lead researcher, Professor Kelvin Tsoi from the Chinese University of Hong Kong, presented the study today at the 25th UEG Week in Barcelona. “The findings demonstrate that the long-term use of aspirin can reduce the risk of developing many major cancers” commented Professor Tsoi. “What should be noted is the significance of the results for cancers within the digestive tract, where the reductions in cancer incidence were all very substantial, especially for liver and oesophageal cancer.” Access the press release in Spanish References 
  1. Tsoi, K. et al. Long-term use of aspirin is more effective to reduce the incidences of gastrointestinal cancers than non-gastrointestinal cancers: A 10-year population based study in Hong Kong. Presented at UEG Week Barcelona 2017.
  2. GLOBOCAN, IARC (2012). Section of Cancer Surveillance.
  3. Stopping aspirin treatment raises cardiovascular risk by over a third (2017). Available at: https://www.medicalnewstoday.com/articles/319541.php
Notes to Editors For further information, or to arrange an interview with Professor Kelvin Tsoi, please contact Luke Paskins on +44 (0)1444 811099 or media@ueg.eu About Professor Kelvin Tsoi Professor Kelvin Tsoi is a research associate Professor of the Stanley Ho Big Data Decision Analytics Research Centre, and an associate Professor of the School of Public Health and Primary Care in the Chinese University Hong Kong. He is a digital epidemiologist and his research interests are in cancer epidemiology and big data research on digital health.    About UEG Week UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning. About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including:  
  • 25th UEG Week, celebrate with us at our jubilee meeting, the biggest congress of its kind in Europe, and one of the two largest in the world
  • UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
  • Activity Grants, funding Live Educational Events, Online Courses and Standards & Guidelines Initiatives organised by UEG Member Societies and other providers.
  • UEG Journal, 10 issues per year covering translational and clinical studies from all areas of gastroenterology
  • EU Affairs, united for digestive health in Europe – prioritising Gastroenterology on the EU health agenda
Find out more about UEG’s work by visiting www.ueg.eu or contact Luke Paskins on +44 (0)1444 811099 or media@ueg.eu Follow UEG on Twitter

UEG Week: New study links protein in wheat to the inflammation of chronic health conditions 

(Vienna, October 17, 2016) Scientists have discovered that a protein in wheat triggers the inflammation of chronic health conditions, such as multiple sclerosis, asthma and rheumatoid arthritis, and also contributes towards the development of non-coeliac gluten sensitivity. 

With past studies commonly focusing on gluten and its impact on digestive health, this new research, presented at UEG Week 2016, turns the spotlight onto a different family of proteins found in wheat called amylase-trypsin inhibitors (ATIs). The study shows that the consumption of ATIs can lead to the development of inflammation in tissues beyond the gut, including the lymph nodes, kidneys, spleen and brain. Evidence suggests that ATIs can worsen the symptoms of rheumatoid arthritis, multiple sclerosis, asthma, lupus and non-alcoholic fatty liver disease, as well as inflammatory bowel disease.

As well as contributing to the development of bowel-related inflammatory conditions, we believe that ATIs can promote inflammation of other immune-related chronic conditions outside of the bowel.

ATIs make up no more than 4% of wheat proteins, but can trigger powerful immune reactions in the gut that can spread to other tissues in the body. Lead researcher, Professor Detlef Schuppan from the Johannes Gutenberg University, Germany, explains, “As well as contributing to the development of bowel-related inflammatory conditions, we believe that ATIs can promote inflammation of other immune-related chronic conditions outside of the bowel. The type of gut inflammation seen in non-coeliac gluten sensitivity differs from that caused by coeliac disease, and we do not believe that this is triggered by gluten proteins. Instead, we demonstrated that ATIs from wheat, that are also contaminating commercial gluten, activate specific types of immune cells in the gut and other tissues, thereby potentially worsening the symptoms of pre-existing inflammatory illnesses”.

Clinical studies are now due to commence to explore the role that ATIs play on chronic health conditions in more detail. “We are hoping that this research can lead us towards being able to recommend an ATI-free diet to help treat a variety of potentially serious immunological disorders” adds Professor Schuppan.

ATIs and Non-Coeliac Gluten Sensitivity

Further to inflaming chronic health conditions outside of the bowel, ATIs may contribute to the development on non-coeliac gluten sensitivity. This condition is now an accepted medical diagnosis for people who do not have coeliac disease but benefit from a gluten free diet. Intestinal symptoms, such as abdominal pain and irregular bowel movements, are frequently reported, which can make it difficult to distinguish from IBS. However, extraintestinal symptoms can assist with diagnosis, which include headaches, joint pain and eczema. These symptoms typically appear after the consumption of gluten-containing food and improve rapidly on a gluten-free diet. Yet, gluten does not appear to cause the condition.

Professor Schuppan hopes that the research will also help to redefine non-coeliac gluten sensitivity to a more appropriate term. He explains, “Rather than non-coeliac gluten sensitivity, which implies that gluten solitarily causes the inflammation, a more precise name for the disease should be considered.”

Access the release in German (PDF)
Access the release in English (PDF)

References 

1.    Zevallos V, Weinmann-Menke J, Meineck M et al. Alpha-amylase/trypsin inhibitors (ATIs) accelerate murine systemic lupus erythematosus. Poster presentation at the 16th International Coeliac Disease Symposium, 21–24 June 2015, Prague, Czech Republic. Poster P168.

2.    Zevallos V, Yogev N, Nikolaev A et al. Consumption of wheat alpha-amylase/trypsin inhibitors (ATIs) enhances experimental autoimmune encephalomyelitis in mice. Oral presentation at the 16th International Coeliac Disease Symposium, 21–24 June 2015, Prague, Czech Republic.

3.    Junker Y, Zeissig S, Kim S-J et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 2012;209(13):2395-408.

4.    Fasano A, Sapone A, Zevallos V et al. Nonceliac gluten and wheat sensitivity. Gastroenterology 2015;148(6):1195-204.

5.    Schuppan D, Pickert G, Ashfaq-Khan M et al. Non-celiac wheat sensitivity: Differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol 2015;29(3):469–76.

Notes to Editors

For further information, or to arrange an interview with Professor Detlef Schuppan, please contact Luke Paskins on +44 (0)1444 811099 or media@ueg.eu

About Professor Detlef Schuppan

Professor Schuppan is from the Institute of Translational Immunology at Mainz University Medical Centre, Germany. Professor Schuppan is an international expert in the fields of fibrosis and coeliac research and is presenting his findings at the Opening Plenary Session at UEG Week Vienna 2016. 

About Professor Antonio Gasbarrini (UEG Spokesperson)

Professor Gasbarrini is a member of the UEG Scientific Committee from the Gemelli University Hospital in Rome, Italy.

About UEG Week

UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress, attracting up to 13,000 participants from 116 countries. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning.

About UEG

UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.

To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including: 

  • UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world.
  • UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
  • Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations
  • UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology
  • EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe

Find out more about UEG’s work by visiting www.ueg.eu or contact:           

Luke Paskins on +44 (0)1444 811099 or media@ueg.eu

 Follow UEG on Twitter

Children’s digestive health across Europe in crisis

(Brussels, 31 May, 2016) A report investigating the current state of digestive health in children has revealed alarming trends in disease incidence and inequalities in the provision of digestive healthcare services for children across Europe. 

‘Paediatric Digestive Health Across Europe’, commissioned by United European Gastroenterology (UEG), is published today and highlights how the current health burden and economic pressure of paediatric digestive health issues, in particular the increasing levels of childhood obesity, have become a pandemic issue throughout the continent.  The report canvasses the opinion of a number of paediatric GI specialists, including experts from UEG and current and past presidents of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), who highlight three particular areas of digestive health that show worrying trends and require urgent action. These include:  
  • In 46 European countries, one in every three children aged 6-9 years is now overweight or obese
  • Childhood onset of inflammatory bowel disease now accounts for 20-30% of all IBD cases
  • Non-alcoholic fatty liver disease has become the most common cause of chronic liver disease among children and adolescents in Western countries, with cases documented in children as young as 3 years old
Commenting on the current state of paediatric digestive health care in Europe, Professor Michael Manns, President of UEG, explains; “Across Europe we have leading paediatric experts and many centres of excellence. However, these are not widespread and currently cannot meet the needs of children throughout the continent. This has an impact on not just individuals and their families but on society and wider health service provision”. A call for change across Europe One of the main findings in the report is that many areas of digestive health follow a ‘one size fits all’ approach with many children following adult care pathways. Professor Berthold Koletzko, President of ESPGHAN, comments; “It is important for stakeholders and policy makers to appreciate that children have complex physical, psychological and social needs and these must be met by trained paediatric specialists to improve the accessibility of optimal care for children today and in future generations”. The report calls for urgent attention and resource investment in paediatric digestive health treatments and services to improve the prognosis for children who suffer from varying digestive health conditions.  A 6 point action plan, targeting key policy makers, stakeholders and health service providers, is outlined within the report to help encourage and deliver change and improve paediatric care across Europe. The 6 key actions are:  
  1. Further development of national strategies and public health campaigns for education, prevention and early intervention
  2. Improve and harmonise training standards through the development of a pan-European digestive health syllabus
  3. Enhance paediatric subspecialty training to understand the complex physical, psychological and social needs of children
  4. Develop transition services as patients move from teenage to adult care
  5. Encourage further research into childhood digestive diseases and early life programming to enable improved prevention strategies
  6. Further development of specialised centres for the optimal management of children with digestive diseases
The report will be issued to European policy makers today at the European Parliament, who will meet with leading health experts to discuss the latest research and areas for development examined in the review. The report is unveiled as part of UEG’s Digestive Health Month to raise awareness of digestive health issues across the continent. “In spite of 20% of the European population being children and the incidence of gastrointestinal diseases increasing, it is extremely worrying that only 1 out of 58 topics currently receiving EU research funding is focused on paediatric health” explains Professor Koletzko. “Priorities need to change quickly to appreciate the specific issues of paediatric digestive provision and ensure greater investment into prevention, cost-effective diagnostic measures and harmonised training”. Professor Manns adds; “UEG hope this report will encourage policy makers, stakeholders and health service providers to adopt the recommendations and prioritise the development of specific paediatric focused strategies for improving the digestive health of children today and for future generations”.

Access the report

Notes to Editors About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. Find out more by visiting www.ueg.eu To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including: 
  • UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world. 
  • NOW OPEN FOR PRESS REGISTRATION
  • UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
  • Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations
  • UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology
  • EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe
About the Report Commissioned by UEG, Paediatric Digestive Health Across Europe, is a report that highlights the current levels of quality in paediatric digestive health throughout Europe, the current state of service provision and the potential impact on longer-term health outcomes and economies. The opinions of leading gastroenterologists and patient organisations have been utilised to help identify priority areas for improvement both now and in the future. Other key trends raised in the report include: 
  • It is predicted that the global number of children under five who are overweight will rise from the current 41 million to 70 million by 2025
  • The high cost of treating obesity and related disorders now represents up to 10% of total healthcare costs and threatens the sustainability of public healthcare systems across Europe
  • Delays in diagnosis of inflammatory bowel disease are taking up to 5 years for 18% of under 18’s
  • Non-alcoholic fatty liver disease prevalence continues to rise among paediatric patients, affecting up to 10% of Europe’s paediatric population
UEG Digestive Health Month The first UEG Digestive Health month, organised by United European Gastroenterology (UEG), has taken place throughout May. Held to raise awareness of digestive health conditions in Europe and highlight opportunities to help advance the treatment and prevention of related diseases, activity has featured on social media via the hashtag #DigestiveHealthMonth Contact Information For further information about the report and UEG’s activities, or to speak to a paediatric digestive health expert please contact Luke Paskins at UEG on +44 (0)1444 811099 or email media@ueg.eu References 
  1. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/policy
  2. United European Gastroenterology Journal: (1) Farthing M, Roberts S, Samuel D, Williams D, et al, Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, 2014 2: 539-543
  3. Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med. 2011; 11:176-178
  4. 1000 Days: http://thousanddays.org/the-issue/obesity/
  5. Early Nutrition Project: http://www.kcl.ac.uk/lsm/research/divisions/wh/newsevents/newsarchive/earlynutritionfactsheet.pdf
  6. B. Wilson, S. Lönnfors, S. Vermeire. The true impact of IBD: a European Crohn's and Ulcerative Colitis patient life. IMPACT Survey 2010-2011 http://efcca.org/media/files/press-Join-Fight/3PRESS_KIT_IBD_IMPACT_REPORT_BCN.pdf
  7. http://www.childliverdisease.org/News/Research-funded-by-Birmingham-charity-identifies-genetic-variant-in-childhood-liver-disease-

UEG Week: Increased risk of large bowel cancer for each 1 cm rise in waist circumference

(Barcelona, October 26, 2015) Experts speaking at the 23rd United European Gastroenterology Week (UEG Week 2015) in Barcelona, Spain today revealed compelling evidence of the link between excess body weight and risk of colorectal cancer (CRC). John Mathers, Professor of Human Nutrition from the Institute of Cellular Medicine at Newcastle University in the UK presented data showing an overall increase of 18% in relative risk of CRC per 5 unit increase in BMI.

“In addition, in men, there is now evidence that increasing waist circumference in middle age is associated with increased bowel cancer risk”, says Prof. Mathers. CRC risk was increased by nearly 60% in men who gained at least 10 cm in waist circumference over 10 years. “This increased cancer risk may be due to persistent inflammation in people with obesity”.

Patients with Lynch Syndrome (LS) have a higher than normal risk of CRC because of an inherited defect in one of the genes responsible for repairing DNA. Prof. Mathers presented new data showing that, in people with Lynch Syndrome, CRC risk increases with higher body weight and for those who are obese the risk of CRC is doubled. Quite surprisingly, the increase in CRC risk with higher body weight in people with Lynch Syndrome was about twice as great as that seen in the general population.

Prof. Mathers said “There is now compelling evidence that improved lifestyle, particularly better dietary choices and being more physically active, can help to prevent obesity and this will lower bowel cancer risk”. In addition, for those people who are already too heavy, losing weight may reduce their CRC risk but this is an area which requires further study. In his studies with Lynch Syndrome patients, Prof. Mathers observed that aspirin lowered the excess CRC risk seen in patients with obesity, perhaps through its anti-inflammatory effects. “This is a very intriguing finding” said Prof Mathers “which suggests that dietary and other anti-inflammatory agents might be beneficial in reducing CRC risk in people with obesity”.

“Bowel cancer is strongly associated with age, obesity and diet – and is driven by inflammation”, explains Prof. Mathers. “We can now give the public clear advice on the benefits of staying physically active, eating a healthy diet and avoiding weight gain to lower CRC risk as we get older”.   Notes to Editors  For further information, or to arrange an interview with Professor Barbara, please contact Luke Paskins on +44 (0)1444 811099 or media@ueg.eu About UEG Week UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning. About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including: 
  • UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world.
  • UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
  • Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations
  • UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology
  • EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe 
Find out more about UEG’s work by visiting www.ueg.eu or contact: Luke Paskins on +44 (0)1444 811099 or media@ueg.eu Follow UEG on Twitter @UEGMedia References 1. Ning Y et al. (2012) Obesity Reviews 11, 19-30 
2. Song M et al. (2015) Int. J. Epidemiol. PMID: 26403814 
3. Movahedi M et al. (2015) J. Clin. Oncol. PMID: 26282643

UEG Week: Obesity and excessive weight gain during pregnancy increase risk of obesity in childhood

(Barcelona, October 26, 2015) Overweight and obese women who gain excessive weight during pregnancy may be putting their babies at risk of a lifetime of obesity. Today, experts from United European Gastroenterology are calling for women of childbearing age to aim to maintain a normal body weight, and for expectant mothers to stay physically active and consume a balanced diet to avoid permanent damage to their child’s health.

Speaking at the 23rd United European Gastroenterology Week (UEG Week 2015) in Barcelona, Spain, Professor Berthold Koletzko from Hauner Children’s Hospital at the University of Munich, Germany, explains that evidence is mounting that excessive weight gain as well as early nutrition play a vital role in many aspects of future health. “We know that a sedentary lifestyle and poor diet in pregnancy increase the risk of children becoming overweight and obese, but we now also think that babies in the womb can have their genetic make-up permanently altered depending on the mother’s diet”, he said. Childhood obesity epidemic The incidence of obesity among children is rising at an alarming rate. According to the World Health Organisation, between 1990 and 2013, the number of obese children aged less than 6 years increased from 32 million to 44 million globally – an increase of almost 40%. If current trends continue, by 2025, it has been estimated there will be 70 million obese young children worldwide. Many factors contribute to the development of obesity in childhood, including the child’s genetic make-up, the consumption of energy-dense, high-fat, high-sugar and high-salt foods, and a lack of physical activity. Studies have also suggested that overweight and obese women at the time when they become pregnant are much more likely to have fatter children than those who are not overweight before or during pregnancy. According to Prof. Koletzko, exposure of the unborn child to an excess of fuels such as glucose and fatty acids may cause permanent metabolic reprogramming in the child that leads to life-long obesity after birth. “Perhaps even more worryingly, these metabolic and epigenetic changes can be passed from generation to generation, which has major public health implications,” he said. Lifestyle during pregnancy and optimized infant feeding Maintaining physical activity and following a balanced diet with limited sugar and saturated fat during pregnancy can be effective in reducing a very high birth weight of babies, a key risk factor for obesity in later life. After birth, improved infant feeding is an effective tool for obesity prevention. In a large controlled study including children in five European countries, Prof. Koletzko and his team demonstrated that an improved infant formula, with lowered protein content - more similar to the protein level in breast milk – lowered the rate of obesity at the early age of 2 by 9 fold, as compared to conventional protein-rich bottle milk. He comments “These results demonstrate that improving nutrition and lifestyle during the first 1,000 days of life, including pregnancy and the first two years of childhood, provide enormous opportunity for improving lifelong health and well-being”. The Early Nutrition Project Prof. Koletzko and researchers from 12 European countries, the USA and Australia have launched the Early Nutrition Project (http://www.project-earlynutrition.eu/eneu/) to study how early nutritional programming and lifestyle factors impact the rates of obesity and related disorders, with a budget of more than 11 million Euros. “We believe that if we can understand how metabolic reprogramming in early life alters an individual’s susceptibility to becoming overweight, we might be able to intervene to prevent or even reverse the process,” he said. Access this press release in Spanish Notes to Editors  For further information, or to arrange an interview with Professor Gasbarrini, please contact Luke Paskins on +44 (0)1444 811099 or media@ueg.eu About UEG Week UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning. About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including: 
  • UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world.
  • UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion
  • Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations
  • UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology
  • EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe 
Find out more about UEG’s work by visiting www.ueg.eu or contact: Luke Paskins on +44 (0)1444 811099 or media@ueg.eu Follow UEG on Twitter @UEGMedia References 1. Koletzko B, Brands B, Chourdakis M, Cramer S, Grote V, Hellmuth C, et al. The Power of Programming and The Early Nutrition Project: opportunities for health promotion by nutrition during the first thousand days of life and beyond. Ann Nutr Metab 2014;64:141–50. 2. Oddy WH, Mori TA, Huang RC, Marsh J, Pennell C, Jacoby P, et al. Early infant feeding and adiposity risk: from infancy to adulthood. Ann Nutr Metab. 2014;64:215–23. 3. Koletzko B, Chourdakis M, Grote H, Hellmuth C, Prell C, Rzehak P, et al. Regulation of early human growth: impact on long-term health. Ann Nutr Metab. 2014;64:141–50. 4. Koletzko B, Bauer CP, Bung P, Cremer M, Flothkotter M, Hellmers C, et al. German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'. Ann Nutr Metab. 2013;63(4):311-22. PubMed PMID: 24514069. Epub 2014/02/12. eng. 5. Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348:g1285. PubMed PMID: 24513442. Pubmed Central PMCID: 3919179. Epub 2014/02/12. eng. 6. Schellong K, Schulz S, Harder T, Plagemann A. Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One. 2012;7(10):e47776. PubMed PMID: 23082214. Pubmed Central PMCID: 3474767.

Vitamin D shows promise for treating Crohn’s disease in pilot study

(June 10, 2015) New research published in this month’s edition of United European Gastroenterology Journal suggests that supplementation with vitamin D may  impact on the intestinal barrier dysfunction associated with Crohn’s disease, and could have a role in the treatment of the condition.

The study is by Professor Maria O’Sullivan and Tara Raftery. Department of Clinical Medicine, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin, Ireland. Crohn’s disease (CD) is a lifelong chronic relapsing and remitting gastrointestinal condition, characterised by inflammation, which can involve any portion of the gastrointestinal tract. CD is associated with abdominal pain, diarrhoea, fatigue and in many cases can result in a reduction of quality of life, time off work, hospitalisations and surgery. The exact causes are unknown; however, immune, genetic and environmental factors are thought to be involved. Incidence of CD varies across Europe, with up to 10 cases per 100,000 population per year. Generally, case rates are higher in northern and western Europe than southern and eastern Europe. There is emerging data that Vitamin D supplementation may prolong remission in CD; however, the clinical efficacy and underlying mechanisms remain unclear. In this new research, the authors aimed to determine changes in gut barrier function (as determined by intestinal permeability and antimicrobial peptide concentrations) as well as disease markers in CD, in response to vitamin D supplementation. In a double-blind randomised placebo-controlled study, the authors assigned 27 CD patients in remission to 2000 IU/day vitamin D supplementation or placebo for 3 months. They found, that patients treated with the supplementation were more likely to maintain their intestinal permeability, whereas this deteriorated in the placebo group. Increased intestinal permeability is considered a measure of gut leakiness, which is shown to predict and precede clinical relapse in CD. In addition, patients with the highest blood levels of vitamin D had signs of reduced inflammation (measured by C-reactive protein and antimicrobial peptides), and these patients also reported better quality of life. The authors conclude: “This is the first reporting of effects of vitamin D supplementation on intestinal permeability and antimicrobial peptide measures in a CD cohort. Whilst the data requires further confirmation, it broadly supports evidence from previous experimental studies that suggest a role for vitamin D in maintaining intestinal barrier integrity.”  Whilst the data is promising, the authors highlight that in order to understand its translation into treatment for CD, further larger randomised controlled trials will be required. UEG’s inflammatory bowel disease expert, Dr Charles Murray of the Royal Free Hospital, London, UK comments; “This is an exciting development in the treatment of Crohn’s disease and we welcome anything new that could potentially help patients with this debilitating condition”. Notes to Editors  Media Contacts Dr Charles Murray, Royal Free Hospital, London, UK - please contact Luke Paskins, UEG. T. +44 (0) 1444 811099.  E. media@ueg.eu Associate Professor Maria O’Sullivan, Department of Clinical Medicine, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin, Ireland. T. + 353 1 896 4039. E. maria.osullivan@tcd.ie About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives, including: · UEG Week, the biggest congress of its kind in Europe, and one of the two largest in the world. MEDIA REGISTRATION NOW OPEN · UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion · Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations · UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology · EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe Find out more about UEG’s work. Visit www.ueg.eu For further information and interviews, please contact:         Luke Paskins: media@ueg.eu Tel: +44 (0)1444 811099 References For the full UEG Journal article, see: http://ueg.sagepub.com/content/early/2015/02/06/2050640615572176.full.pdf+html For further information on incidence of Crohn’s disease in Europe, see: https://ueg.eu/epaper/WhiteBook.Brochure/index.html#/6

Eating less salt may reduce the risk of stomach cancer: UEG calls for greater salt-awareness across Europe.

(Vienna January, 12, 2015) Stomach cancer is diagnosed in around 80,000 people in the European Union (EU) each year and is associated with a very poor prognosis. The most well-established risk factor for stomach cancer is infection with Helicobacter pylori (H. pylori), which causes inflammation within the stomach that can progress to stomach cancer.

Now scientists believe that eating too much salt also increases the risk of stomach cancer, with a direct relationship found between salt consumption and cancer risk. According to Professor John Atherton, UEG Secretary General and a leading H. pylori expert, the combination of H. pylori infection and a high salt intake appears to be especially dangerous. “Although we don’t know exactly why salt increases the risk of stomach cancer, studies suggest that it may encourage the growth of H. pylori and make it more toxic to the cells of the stomach,” he says. Stomach cancer in the EU The recent Survey of Digestive Health Across Europe reported that more than 80,000 new cases of stomach cancer were identified in the EU in 2012, with twice as many men as women affected. H. pylori infection, which typically occurs during childhood and is difficult to detect, has been estimated to be responsible for around three-quarters of all stomach cancers. Excessive salt consumption is thought to contribute to a quarter of all cases. “Most of us know that salt is associated with high blood pressure and an increased risk of heart disease and stroke,” says Prof. Atherton. “However, I suspect very few people are aware that a high-salt diet may also increase the risk of stomach cancer.” Salt consumption guidelines The European Commission and many individual European countries have taken positive action towards reducing salt consumption across the continent. Current guidelines from the World Health Organisation (WHO) suggest that no more than 5 g of salt (less than 1 teaspoon) should be eaten per day – a challenging target given that most salt in our diets is not added by us, but comes from processed foods such as bread, cheese, breakfast cereals and ready meals. “In the UK, our salt target for adults is no more than 6 g per day, which should theoretically reduce the risk of stomach cancer as well as other salt-related health problems,” says Prof. Atherton. “Although we need more studies to confirm that eating a low-salt diet reduces the incidence of stomach cancer, there is preliminary evidence from Japan to suggest this would be the case.” It is straightforward to reduce salt in your diet: take special care when shopping to, buy low-salt versions of your favourite foods; moderate your intake of some foods such as cured meat, bread, cheese and table sauces; and to add no salt during cooking or at the table. This will reduce your risk of a variety of diseases, particularly heart disease and stroke and it now looks as though it will also reduce your risk of developing stomach cancer. References: 1. WHO International Agency for Research on Cancer. http://eu-cancer.iarc.fr/. 2. D’Elia L, Rossi G, Ippolito R, et al. Clin Nutr 2012;31(4):489–98. 3. Roberts SE, Samuel DG, Williams JG, et al. Survey of Digestive Health across Europe. Part one: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe. Report for United European Gastroenterology. August 2014. 4. Parkin DM. Br J Cancer 2011;105:S31–S33. 5. Tominaga S, Kuroishi T. Int J Cancer 1997;10(Suppl):2–6. 6. World Action on Salt & Health. Salt and stomach cancer. Available at: http://www.worldactiononsalt.com/salthealth/factsheets/stomach/index.html. Last accessed 5 January 2015. Notes to Editors About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. Find out more about UEG’s work, visit www.ueg.eu Available for interview UEG Spokesperson, Professor John Atherton is the UEG Secretary General and also a leading H. pylori expert at The University of Nottingham. Press contact Samantha Forster media@ueg.eu Tel: +44 (0)1444 811099 @UEGMedia

Wheat-related disorders – Gluten-free diet may do more harm than good.

(September 18 , 2014) Cereals such as wheat have long been considered a fundamental food source, yet growing numbers of people are intolerant to them and the list of wheat-related conditions seems to grow daily. Now, experts are calling for a greater awareness of wheat-related disorders in order that gluten-intolerant patients are diagnosed more swiftly and receive the best possible treatment.

Cereals such as wheat have long been considered a fundamental food source, yet growing numbers of people are intolerant to them and the list of wheat-related conditions seems to grow daily. Now, experts are calling for a greater awareness of wheat-related disorders in order that gluten-intolerant patients are diagnosed more swiftly and receive the best possible treatment. According to a paper, ‘Wheat-related disorders: A broad spectrum of ‘evolving’ diseases,’ published in this month’s UEG Journal,experts Professor Giovanni Gasbarrini and Dr Francesca Mangiola suggest that people eating a gluten-free diet may also be at risk of developing new food intolerances, due to excessive substitution of alternative carbohydrates and foods containing nickel which may lead to additional health problems. They offer the following practical advice to clinicians on how to differentiate between coeliac disease and other gluten-related disorders to diagnose conditions more effectively and ensure sufferers do not follow a gluten-free diet unnecessarily: ·         Perform a thorough medical history, with particular attention given to the native gut microbiota. ·         Extensively explore the symptoms and assess the presence of any history of allergies. ·         Evaluate the genetic background with great care because it is often important to target or confirm the diagnosis and in some cases, make it unlikely. Gluten: the wheat toxin Gluten is a substance found in wheat, barley and rye that is composed of the two proteins, gliaden and glutenin. Researchers believe that gliaden is the gluten component people react to when they have wheat-related disorders. A number of distinct medical conditions are now recognised to be gluten-related including coeliac disease, wheat allergy and the newly-defined condition, non-coeliac gluten sensitivity. According to Gasbarrini and Mangiola’s paper, among the problematic disorders related to gluten, around 10% may be wheat allergy, 6% may be non-coeliac gluten sensitivity and only 1% is coeliac disease.1 Commenting on the article, UEG Spokesperson, Professor Antonio Gasbarrini said it is important to raise awareness of wheat-related disorders in order that people are not left undiagnosed and suffering. “Gluten-related disorders, like all food allergies, are extremely disabling and can have a major impact on people’s lives,” he said. “Most of us have heard of coeliac disease, but the other conditions are also very distressing and they are far more common.” “Many clinicians struggle to differentiate between the wheat-related disorders so practical advice like this is always helpful,” adds Prof. Gasbarrini. “Hopefully, as clinicians and patients become more aware of the range of conditions associated with wheat and gluten, the quicker they can be diagnosed, receive the most appropriate treatment and prevent associated health problems.” Reference 1.     Gasbarrini GB, Mangiola F. Wheat-related disorders: A broad spectrum of ‘evolving’ diseases. United European Gastroenterol J 2014;2(4):254-62. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114114/. Notes to Editors About UEG Week UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning. About UEG UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives besides UEG Week, including:    ·        UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion  ·         Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations ·        UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology ·        EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe Find out more about UEG’s work. Visit www.ueg.eu

Press contact    

Samantha Forster:

Email: media@ueg.eu

Tel: +44 (0)1444 811099

 

The Growing Obesity Issue

Obesity, a growing problem throughout Europe, has been shown to be strongly correlated with a number of digestive health diseases.